Shares of GW Pharmaceuticals (Nasdaq: GWPH) continued rising by leaping $8.46 to close at $69.32 after Morgan Stanley set a $103 price target on the medical marijuana company yesterday.
GW Pharmaceuticals Extends Gains
April 23, 2014 at 17:44 PM EDT